Annie Bourdeau
Overview
Explore the profile of Annie Bourdeau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
643
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bourdeau A, van Slyke P, Kim H, Cruz M, Smith T, Dumont D
BMC Res Notes
. 2016 May;
9:289.
PMID: 27236199
Background: Earlier studies by our group have demonstrated that a transgenic animal engineered to express Tie2 under the control of the Tie2 promoter produced animals with a scaly skin phenotype...
2.
Cydzik M, Abdul-Wahid A, Park S, Bourdeau A, Bowden K, Prodeus A, et al.
FASEB J
. 2015 Apr;
29(8):3493-505.
PMID: 25921830
VEGF-A (VEGF) drives angiogenesis through activation of downstream effectors to promote endothelial cell proliferation and migration. Although VEGF binds both VEGF receptor 1 (R1) and receptor 2 (R2), its proangiogenic...
3.
Trop S, Marshall J, Mazer C, Gupta M, Dumont D, Bourdeau A, et al.
J Surg Res
. 2013 Nov;
187(1):43-52.
PMID: 24176205
Background: South Asian ethnicity is an independent risk factor for mortality after coronary artery bypass. We tested the hypothesis that this risk results from a greater inflammatory response to cardiopulmonary...
4.
Kim H, Cruz M, Bourdeau A, Dumont D
PLoS One
. 2013 Jan;
8(1):e52197.
PMID: 23341894
Lymphangiogenesis is a highly regulated process that involves the reprogramming of venous endothelial cells into early lymphatic endothelial cells. This reprogramming not only displays a polarized expression pattern from the...
5.
Bourdeau A, Trop S, Doody K, Dumont D, Tremblay M, Tremblayef M
Stem Cells
. 2012 Nov;
31(2):293-304.
PMID: 23135963
The clinical application of hematopoietic progenitor cell-based therapies for the treatment of hematological diseases is hindered by current protocols, which are cumbersome and have limited efficacy to augment the progenitor...
6.
Heinonen K, Bourdeau A, Doody K, Tremblay M
Proc Natl Acad Sci U S A
. 2009 May;
106(23):9368-72.
PMID: 19474293
The control of tyrosine phosphorylation depends on the fine balance between kinase and phosphatase activities. Protein tyrosine phosphatase 1B (PTP-1B) and T cell protein tyrosine phosphatase (TC-PTP) are 2 closely...
7.
Cencic R, Carrier M, Galicia-Vazquez G, Bordeleau M, Sukarieh R, Bourdeau A, et al.
PLoS One
. 2009 Apr;
4(4):e5223.
PMID: 19401772
Background: Flavaglines are a family of natural products from the genus Aglaia that exhibit anti-cancer activity in vitro and in vivo and inhibit translation initiation. They have been shown to...
8.
Doody K, Bourdeau A, Tremblay M
Immunol Rev
. 2009 Mar;
228(1):325-41.
PMID: 19290937
The immune system requires for its proper ontogeny, differentiation, and maintenance the function of several tyrosine kinases and adapters that create and modify tyrosine phosphorylation sites. Tyrosine phosphorylation is a...
9.
Trop S, Tremblay M, Bourdeau A
Trends Cardiovasc Med
. 2008 Sep;
18(5):180-6.
PMID: 18790388
Adult bone marrow contains stem cells capable of reconstituting the vascular system. The ordered progression of stem cells and more differentiated endothelial precursor cells through successive developmental stages is tightly...
10.
Bourdeau A, Dube N, Heinonen K, Theberge J, Doody K, Tremblay M
Blood
. 2007 Jan;
109(10):4220-8.
PMID: 17234741
The T-cell protein tyrosine phosphatase (TC-PTP) is a negative regulator of the Jak/Stat cytokine signaling pathway. Our study shows that the absence of TC-PTP leads to an early bone marrow...